Axsome Therapeutics
The Senior Manager, Finance is responsible for preparing Axsome Therapeutics' external financial reporting, including SEC filings and technical accounting research. This role supports the design and testing of internal controls under SOX 404 and serves as a trusted business partner across finance, legal, and investor relations teams. The position is based in New York City with a requirement to work on-site at least three days per week.
Headquarters
New York, New York, United States
Company Size
201-500 employees
Founded
2012
Axsome Therapeutics is a biopharmaceutical company focused on developing novel therapies for central nervous system (CNS) conditions that have limited treatment options. Its pipeline and commercial programs include candidates such as AXS-05, AXS-12 and AXS-14, addressing disorders including major depressive disorder, Alzheimer’s disease agitation, migraine, narcolepsy and fibromyalgia. Axsome emphasizes innovative mechanisms of action and rigorous clinical development to deliver meaningful improvements in patient outcomes. The company is headquartered in New York City and advances programs through regulatory engagement and commercialization efforts.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Axsome Therapeutics.
Axsome Therapeutics, Inc. (AXSM): A Bull Case Theory
2 weeks ago
Senior Manager, SEC Reporting & Technical Accounting
Align Technology
Senior Accountant, Compliance & SEC Reporting
Sarepta Therapeutics
Senior Technical Accountant (SEC)
Clark Davis Associates
Manager of Corporate Reporting
Lionsgate
SEC Reporting Manager
Transamerica
Senior Accountant, SEC Reporting
NeoGenomics Laboratories